Drug
Memantine Oral Tablet
Memantine Oral Tablet is a pharmaceutical drug with 5 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Total Trials
5
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
1(20%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_2
1
20%
Ph phase_3
2
40%
Ph phase_4
2
40%
Phase Distribution
0
Early Stage
1
Mid Stage
4
Late Stage
Phase Distribution5 total trials
Phase 2Efficacy & side effects
1(20.0%)
Phase 3Large-scale testing
2(40.0%)
Phase 4Post-market surveillance
2(40.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
100.0%
1 of 1 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
5
all time
Status Distribution
Active(2)
Completed(1)
Other(2)
Detailed Status
unknown2
Recruiting1
Not yet recruiting1
Completed1
Development Timeline
Analytics
Development Status
Total Trials
5
Active
1
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 21 (20.0%)
Phase 32 (40.0%)
Phase 42 (40.0%)
Trials by Status
recruiting120%
not_yet_recruiting120%
unknown240%
completed120%
Recent Activity
1 active trials
Showing 5 of 5
completedphase_4
Satisfaction With Orodispersible vs Conventional Memantine in Moderate to Severe Alzheimer's Disease
NCT07417670
recruitingphase_3
Evaluation of Memantine in the Preservation of Memory and Neurocognition Following CSI
NCT06275035
not_yet_recruitingphase_2
Early Application of Memantine and Pioglitazone to Protect Cognitive Function After Radiotherapy
NCT06594172
unknownphase_4
Efficacy and Safety of Memantine and Sodium Oligomannate in Patients With Moderate to Severe Alzheimer's Disease
NCT05430867
unknownphase_3
Memantine for Refractory OCD Patients
NCT05015595
Clinical Trials (5)
Showing 5 of 5 trials
NCT07417670Phase 4
Satisfaction With Orodispersible vs Conventional Memantine in Moderate to Severe Alzheimer's Disease
NCT06275035Phase 3
Evaluation of Memantine in the Preservation of Memory and Neurocognition Following CSI
NCT06594172Phase 2
Early Application of Memantine and Pioglitazone to Protect Cognitive Function After Radiotherapy
NCT05430867Phase 4
Efficacy and Safety of Memantine and Sodium Oligomannate in Patients With Moderate to Severe Alzheimer's Disease
NCT05015595Phase 3
Memantine for Refractory OCD Patients
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5